JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Comparison of Epstein-Barr virus copy number in white blood cells of chronic lymphocytic leukemia patients with laboratory prognostic biomarker

  • 0Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, P.O. Box: 71345-1735, Shiraz, Iran.
Bmc Research Notes +

|

October 1, 2024

|

October 1, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Epstein-Barr virus (EBV) DNA load may indicate prognosis in chronic lymphocytic leukemia (CLL). Higher EBV viral loads correlate with severe disease markers, suggesting its use as an initial prognostic factor for CLL patients.

Area Of Science

  • Hematology
  • Virology
  • Oncology

Background

  • Epstein-Barr virus (EBV) DNA load is implicated in chronic lymphocytic leukemia (CLL) pathogenesis and prognosis.
  • This study investigates the prognostic significance of EBV viral load in CLL.

Purpose Of The Study

  • To evaluate the prognostic value of EBV DNA load in untreated CLL patients.
  • To compare EBV viral load with established laboratory prognostic factors.

Main Methods

  • Collected whole blood and sera from 40 untreated CLL patients.
  • Quantified EBV DNA load using TaqMan real-time PCR targeting the BNRF1 gene.
  • Assessed complete blood counts (CBC) and lactate dehydrogenase (LDH) levels.

Main Results

  • 52.5% of patients were EBV DNA positive, with viral loads ranging from 20 to 30,000 copies/µL.
  • EBV-positive patients showed significant differences in LDH levels, platelet counts, and CD5+/CD19+ counts compared to EBV-negative patients.
  • Severe CLL forms (high LDH, low platelets, 11q deletion) exhibited considerably higher EBV DNA loads.

Conclusions

  • EBV DNA load can serve as a prognostic factor in the initial assessment of CLL.
  • Utilizing EBV DNA load can enhance disease outcome characterization and prognosis prediction in CLL.

Keywords: